| Management target | Revenue 15.0% FY27 |
|---|
| Revenue growth | 21% YoY revenue growth driven by volume expansion and genomics. |
|---|---|
| Margins | EBITDA margins expanded to 36%; mature centers at 40.9%. |
| Demand visibility | Strong, specifically in specialized genomics and pathology across Eastern India. |
| Management confidence | Confident, highlighting strong execution in expansion and genomics adoption. |
Growth
Revenue grew 21% YoY; genomics vertical surged 136% YoY; EBITDA margins expanded to 36% from 34%.
Outlook
Management guides for 15% revenue growth for FY27 and plans to reach 100 centers by FY28.
Risks
Seasonal weakness in Q3; regional concentration in Eastern India; margin pressure from rapid new center ramp-ups.
Last quarter's promises, checked
Delivered
- Guided 15% revenue growth → delivered 21% (= BEAT)
- Guided 33% EBITDA margin → delivered 36% (= BEAT)
- Guided 5 hubs and 8 spokes addition → delivered 10 centers (= BEAT)
Partly delivered
- Guided INR 70Cr capex → delivered INR 70-80Cr range (= PARTIAL)
Earnings Call Transcript filed with BSE, NSE: SURAKSHA. Summary written with AI assistance from the document.
Suraksha Diagnostic Ltd: key numbers
- Share price
- ₹324.10
- Market cap
- ₹1,688 Cr
- Revenue (annual)
- ₹310.4 Cr
- Net profit (annual)
- ₹32.19 Cr
- P/E (TTM)
- 47.1×Sector 53.1×
- Promoter holding
- 49.10%+0.00% QoQ
- FII holding
- 13.47%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Suraksha Diagnostic Ltd
All →Suraksha Diagnostic Annual General Meeting
Suraksha Diagnostic Ltd held its 21st AGM on September 22, 2026. Members adopted financial statements, approved a final dividend, and ratified cost auditor remuneration.
Suraksha Diagnostic Annual General Meeting
Suraksha Diagnostic Limited has issued a notice for its 21st Annual General Meeting scheduled for September 22, 2026, to conduct routine business and dividend declaration.
- Value
- ₹0.01 Cr
Suraksha Diagnostic Annual General Meeting
Suraksha Diagnostic Limited has issued a notice for its 21st Annual General Meeting to be held on September 22, 2026, to transact key corporate business.
Suraksha Diagnostic Other Announcement
Suraksha Diagnostic informed exchanges about dispatching letters to shareholders with unregistered emails, providing web links to access the 21st AGM notice and Annual Report.
Suraksha Diagnostic Annual Report
Suraksha Diagnostic Limited has filed its Annual Report for FY 2025-26, including the notice for the 21st Annual General Meeting scheduled for September 22, 2026.
Suraksha Diagnostic Investor Presentation: Key Takeaways
Suraksha Diagnostic reported strong Q1 FY27 results with 21% YoY revenue growth and 14.7% PAT margin. Management is aggressively expanding the hub-and-spoke network beyond West Bengal into Jharkhand and Tripura.